122 related articles for article (PubMed ID: 37084769)
1. Feasibility of partial-orbit irradiation as a treatment strategy for patients with orbital mucosa-associated lymphoid tissue lymphoma.
Chung SY; Kook KH; Oh YT
Can J Ophthalmol; 2024 Jun; 59(3):e227-e232. PubMed ID: 37084769
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome, relapse patterns, and toxicity after radiotherapy for orbital mucosa-associated lymphoid tissue lymphoma: implications for radiotherapy optimization.
Lee J; Yoon JS; Kim JS; Koom WS; Cho J; Suh CO
Jpn J Clin Oncol; 2019 Jul; 49(7):664-670. PubMed ID: 31505651
[TBL] [Abstract][Full Text] [Related]
3. Effects of radiation therapy on the meibomian glands and dry eye in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma.
Kim SE; Yang HJ; Yang SW
BMC Ophthalmol; 2020 Jan; 20(1):24. PubMed ID: 31931766
[TBL] [Abstract][Full Text] [Related]
4. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT Lymphoma).
Son SH; Choi BO; Kim GW; Yang SW; Hong YS; Choi IB; Kim YS
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):86-91. PubMed ID: 19632068
[TBL] [Abstract][Full Text] [Related]
5. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity.
Goda JS; Le LW; Lapperriere NJ; Millar BA; Payne D; Gospodarowicz MK; Wells W; Hodgson DC; Sun A; Simpson R; Tsang RW
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e659-66. PubMed ID: 21640514
[TBL] [Abstract][Full Text] [Related]
6. Orbital lymphoma: is it necessary to treat the entire orbit?
Pfeffer MR; Rabin T; Tsvang L; Goffman J; Rosen N; Symon Z
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):527-30. PubMed ID: 15380588
[TBL] [Abstract][Full Text] [Related]
7. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior.
Suh CO; Shim SJ; Lee SW; Yang WI; Lee SY; Hahn JS
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):228-33. PubMed ID: 16503386
[TBL] [Abstract][Full Text] [Related]
8. Partial orbit irradiation achieves excellent outcomes for primary orbital lymphoma.
Binkley MS; Hiniker SM; Donaldson SS; Hoppe RT
Pract Radiat Oncol; 2016; 6(4):255-261. PubMed ID: 26935235
[TBL] [Abstract][Full Text] [Related]
9. Treatment effects and sequelae of radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma.
Hata M; Omura M; Koike I; Tomita N; Iijima Y; Tayama Y; Odagiri K; Minagawa Y; Ogino I; Inoue T
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1387-93. PubMed ID: 20950950
[TBL] [Abstract][Full Text] [Related]
10. Radiation therapy for orbital lymphoma.
Zhou P; Ng AK; Silver B; Li S; Hua L; Mauch PM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):866-71. PubMed ID: 15925453
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of low dose radiotherapy for primary orbital marginal zone lymphoma.
Tran KH; Campbell BA; Fua T; MacManus M; Ryan G; Chesson B; Wirth A
Leuk Lymphoma; 2013 Mar; 54(3):491-6. PubMed ID: 23020137
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy.
Parikh RR; Moskowitz BK; Maher E; Della Rocca D; Della Rocca R; Culliney B; Shapira I; Grossbard ML; Harrison LB; Hu K
Leuk Lymphoma; 2015 May; 56(5):1266-70. PubMed ID: 25356924
[TBL] [Abstract][Full Text] [Related]
13. Patterns of care for orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in Korea throughout 2016: Results from a multicenter cross-sectional cohort study (KROG 16-19).
Lee J; Oh D; Choi BO; Eom KY; Lee JH; Kim JH; Lee SW; Suh YK; Suh CO
Asia Pac J Clin Oncol; 2019 Dec; 15(6):358-363. PubMed ID: 31264373
[TBL] [Abstract][Full Text] [Related]
14. Oral chlorambucil for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue of the orbit.
Ben Simon GJ; Cheung N; McKelvie P; Fox R; McNab AA
Ophthalmology; 2006 Jul; 113(7):1209-13. PubMed ID: 16647129
[TBL] [Abstract][Full Text] [Related]
15. Localized ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiation therapy: a long-term outcome in 86 patients with 104 treated eyes.
Harada K; Murakami N; Kitaguchi M; Sekii S; Takahashi K; Yoshio K; Inaba K; Morota M; Ito Y; Sumi M; Suzuki S; Tobinai K; Uno T; Itami J
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):650-4. PubMed ID: 24521680
[TBL] [Abstract][Full Text] [Related]
16. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
[TBL] [Abstract][Full Text] [Related]
17. Primary radiotherapy for localized orbital MALT lymphoma.
Le QT; Eulau SM; George TI; Hildebrand R; Warnke RA; Donaldson SS; Hoppe RT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):657-63. PubMed ID: 11849787
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent.
Teckie S; Qi S; Lovie S; Navarrett S; Hsu M; Noy A; Portlock C; Yahalom J
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):130-7. PubMed ID: 25863760
[TBL] [Abstract][Full Text] [Related]
19. Severe retinopathy following radiation therapy with a moderate dose for orbital mucosa-associated lymphoid tissue lymphoma.
Hata M; Kaneko A; Tomita N; Inoue T
Hematol Oncol; 2014 Dec; 32(4):212-4. PubMed ID: 25471380
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
